Aug 2026· Frontiers in Medicine· Vol 13· 0 citations· 23 references
Medicine
TL;DR
The Tamil Nadu cohort provides regional evidence on age-stratified cytogenetic risk in AMA pregnancies and supports the use of clearly defined criteria for integrating CMA with conventional karyotyping in prenatal diagnosis.
Abstract
Background Advanced maternal age (AMA; > = 35 years) is associated with increased fetal chromosomal risk and is an important indication for invasive prenatal diagnosis. This study evaluates karyotyping and chromosomal microarray analysis (CMA) findings among AMA pregnancies in Tamil Nadu, India. Methods In this prospective observational study, 2,200 pregnant women aged ≥35 years who underwent amniocentesis between July 2020 and June 2021 were enrolled. Conventional karyotyping was performed in all cases. CMA was performed as a reflex or complementary test when predefined clinical or cytogenetic criteria were present, including ultrasound abnormalities, high-risk screening/NIPT results, abnormal or uncertain karyotype findings, prior adverse pregnancy history suggestive of genetic etiology, parental chromosomal abnormalities, or patient request after counseling. Results Numerical chromosomal abnormalities were detected in 76/2200 cases (3.5%), and structural abnormalities were detected in 9/2200 cases (0.4%). The total abnormal cytogenetic yield was therefore 85/2200 cases (3.9%) when numerical and structural abnormalities were considered together. Age-stratified analysis showed an increasing trend in chromosomal abnormalities with advancing maternal age, reaching 10.4% in women aged > = 43 years. Cases with additional clinical indications showed higher abnormality rates than simple AMA. CMA was performed in selected cases and contributed to characterization of clinically relevant genomic abnormalities, supporting its role in indicated high-risk AMA pregnancies. Conclusion The Tamil Nadu cohort provides regional evidence on age-stratified cytogenetic risk in AMA pregnancies and supports the use of clearly defined criteria for integrating CMA with conventional karyotyping in prenatal diagnosis.
Most evidence on chromosomal microarray analysis (CMA) and exome sequencing (ES) in prenatal diagnosis comes from high-volume centres. We evaluated the incremental diagnostic contribution of additional testing modalities, non-invasive prenatal testing (NIPT) confirmation rates and pregnancy outcomes at a regional centr...
SUA was most common in pregnant women aged 25–35 and significantly higher in primigravidas and nulliparous women with a history of miscarriage and Chromosomal abnormality rates increased with associated malformation number and occurred even in iSUA.
Yu-Qing Chen, Xiao-Qing Wu, Mei-Ying Cai et al.· Genetics Research· 0 citations
It is suggested that the type of first-trimester ultrasound abnormality is associated with prenatal test selection, and the importance of individualized genetic counseling when discussing prenatal testing options and residual uncertainty following abnormal ultrasound findings is highlighted.
Koutarou Doi, Masatoshi Yamaguchi, Minayo Iwai et al.· Journal of Genetic Counselin...· 0 citations
QF-PCR provides a rapid and reliable preliminary assessment for common aneuploidies in cordocentesis cases; however, conventional cytogenetic analysis remains essential for definitive diagnosis due to its ability to detect structural and rare chromosomal abnormalities.
Ceren Sağlam Purut, Sevim Tuncer Can, Raziye Torun et al.· Southern Clinics of Istanbul...· 0 citations
Background With the widespread application of chromosomal microarray analysis (CMA) in prenatal diagnosis, fetal gallbladder abnormalities have been found to be associated not only with chromosomal aneuploidies but also with certain syndromes caused by submicroscopic chromosomal structural variants. This study aimed to...
Xiao-Rui Xie, Xiao-Qing Wu, Ying Li et al.· PLoS ONE· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.